Last reviewed · How we verify
NL005 Middle Dose
At a glance
| Generic name | NL005 Middle Dose |
|---|---|
| Also known as | NL005（ Middle Dose） |
| Sponsor | Beijing Northland Biotech. Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction (PHASE2)
- Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.Infarction (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |